Literature DB >> 9469716

Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR.

E R Seaquist1, R Gruetter.   

Abstract

The peak at 3.35 ppm in the 1H-NMR spectrum characteristic for scyllo-inositol may be a marker for cerebral pathology, although it has a well-known constant concentration relative to myo-inositol. Such a peak was observed with an intensity at least 300% above normal in the brain of a healthy volunteer. The scyllo-inositol signal was assigned based on the detection of a corresponding peak at 74.5 ppm in the 13C-NMR spectrum and on the demonstration of singlet characteristics of the proton signal. The presence of substantial brain concentrations of scyllo-inositol suggests that scyllo-inositol metabolism may be regulated independently from myo-inositol and that such concentrations are compatible with normal health.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469716     DOI: 10.1002/mrm.1910390220

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  10 in total

1.  Glial neoplasms without elevated choline-creatine ratios.

Authors:  Brian C Bowen
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.

Authors:  Ji-Kyung Choi; Isabel Carreras; Alpaslan Dedeoglu; Bruce G Jenkins
Journal:  Neuropharmacology       Date:  2010-04-22       Impact factor: 5.250

Review 3.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

Review 4.  In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models.

Authors:  In-Young Choi; Sang-Pil Lee; David N Guilfoyle; Joseph A Helpern
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

5.  Neuropsychological function and cerebral metabolites in HIV-infected youth.

Authors:  R Nagarajan; M K Sarma; M A Thomas; L Chang; U Natha; M Wright; J Hayes; K Nielsen-Saines; D E Michalik; J Deville; J A Church; K Mason; T Critton-Mastandrea; S Nazarian; J Jing; M A Keller
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-13       Impact factor: 4.147

Review 6.  Localized in vivo 13C NMR spectroscopy of the brain.

Authors:  Rolf Gruetter; Gregor Adriany; In-Young Choi; Pierre-Gilles Henry; Hongxia Lei; Gülin Oz
Journal:  NMR Biomed       Date:  2003 Oct-Nov       Impact factor: 4.044

7.  High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.

Authors:  A Viola; F Nicoli; B Denis; S Confort-Gouny; Y Le Fur; J-P Ranjeva; P Viout; P J Cozzone
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

8.  Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla.

Authors:  Lana G Kaiser; Norbert Schuff; Nathan Cashdollar; Michael W Weiner
Journal:  NMR Biomed       Date:  2005-02       Impact factor: 4.044

9.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

10.  Sodium/myo-Inositol transporters: substrate transport requirements and regional brain expression in the TgCRND8 mouse model of amyloid pathology.

Authors:  Daniela Fenili; Ying-Qi Weng; Isabelle Aubert; Mark Nitz; JoAnne McLaurin
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.